Resumen
Objetivo: Evaluar factores sociodemográficos, de adherencia y clínico-laboratorios como potenciales predictores de buen y mal control glucémico en pacientes con diagnóstico de Diabetes Mellitus tipo 2 (DM2). Métodos: Se realizó un estudio observacional y retrospectivo con 100 pacientes en un centro de referencia de tratamiento de diabetes en Río de Janeiro, que tuvo como objetivo identificar predictores de buen y mal control glucémico en pacientes diabéticos tipo 2, durante el período de 2018 a 2020. Se correlacionaron variables sociodemográficas, de salud y de tratamiento con los niveles de hemoglobina glucosilada (HbA1c), estratificadas en CUARTILES y divididas en muy buena, buena, mala y muy mala. Resultados: En la muestra predominó el mal control glucémico (33%) y se observó que el género (p=0,013), la edad al diagnóstico de diabetes (p=0,016), la adherencia al autocontrol (p=0,002) y seguimiento anual con oftalmólogo (p=0,036) fueron las variables que se presentaron como predictoras de los niveles de hemoglobina glucosilada. Conclusión: La investigación de predictores de buen control glucémico es importante dada la alta prevalencia de Diabetes y sus complicaciones, y sirve de base para intervenciones más efectivas en el tratamiento.
Referencias
AL-MA'AITAH OH, et al. Glycaemic control and its associated factors in patients with type 2 diabetes in the Middle East and North Africa: An updated systematic review and meta-analysis. J Adv Nurs. 2022;78(8):2257-2276.
AMERICAN DIABETES ASSOCIATION. Disclosures: Standards of Medical Care in Diabetes- 2020 Diabetes Care. 2020. Disponível em: https://diabetesjournals.org/care/article/43/Supplement_1/S205/30757/Disclosures-Standards-of-Medical-Care-in-Diabetes. Acessado em: 17 de abril de 2023.
AMERICAN DIABETES ASSOCIATION. Glycemic Targets: Standards of Medical Care in Diabetes – 2022. 2022. Disponivel em: https://diabetesjournals.org/care/article/45/Supplement_1/S83/138927/6-Glycemic-Targets-Standards-of-Medical-Care-in. Acessado em: 3 de setembro de 2023.
BABANIAMANSOUR S, et al. Glycemic control and associated factors among Iranian population with type 2 diabetes mellitus: a cross-sectional study. J Diabetes Metab Disord. 2020 Jul 8;19(2):933-940.
BERGENSTAL RM, et al. Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes. J Diabetes Complications. 2022;36(3):108106.
BRASIL. Pesquisa Nacional de Saúde 2019: percepção do estado de saúde, estilos de vida, doenças crônicas e saúde bucal: Brasil, grandes regiões. 2020. Disponível em: https://biblioteca.ibge.gov.br/visualizacao/livros/liv101764.pdf. Acessado em: 17 de abril de 2023
DEPARTMENT OF HEALTH AND HUMAN SERVICES. 2018 Physical Activity Guidelines Advisory Committee Scientific Report. 2018. Disponível em: https://health.gov/sites/default/files/2019-09/PAG_Advisory_Committee_Report.pdf. Acessado em: 17 de abril de 2023.
DUARTE F, et al. Sex differences and correlates of poor glycaemic control in type 2 diabetes: a cross-sectional study in Brazil and Venezuela. BMJ Open. 2019;9(3): e023401.
FELDMAN EL. Management of diabetic neuropathy. UpToDate. Waltham, MA: UpToDate 2022.
FRANCISCO P, et al. Prevalence of concomitant hypertension and diabetes in Brazilian older adults: individual and contextual inequalities. Prevalência simultânea de hipertensão e diabetes em idosos brasileiros: desigualdades individuais e contextuais. Cien Saude Colet. 2018;23(11):3829-3840.
INTERNATIONAL DIABETES FEDERATION. IDF Diabetes Atlas, 9th edn. 2019. Disponível em: https://www.diabetesatlas.org. Acessado em: 3 de setembro de 2023
INZUCCHI S, LUPSA B. Clinical presentation, diagnosis, and initial evaluation of diabetes mellitus in adults. UpToDate. Waltham, MA: UpToDate 2023.
KUMAH E, et al. Self-management Education Program: The Case of Glycemic Control of Type 2 Diabetes. Oman Med J. 2021;36(1):e225
BRASIL. Vigitel Brasil 2019: Estimativas sobre frequência e distribuição sociodemográfica de fatores de risco e proteção para doenças crônicas nas capitais dos 26 estados brasileiros e no distrito federal em 2019.
Disponível em: https://bvsms.saude.gov.br/bvs/publica coes/vigitel_brasil_2019_vigilancia_fatores_risco.pdf. Acessado em: 17 de abril de 2023
MROUEH L et al, Evaluation of medication adherence among Lebanese diabetic patients. Pharmacy practice. 2018,16(4):1291
SA CHOE, et al. Women are less likely than men to achieve optimal glycemic control after 1 year of treatment: A multi-level analysis of a Korean primary care cohort. PLoS One. 2018;13(5):e0196719
SOCIEDADE BRASILEIRA DE DIABETES. Diretrizes da sociedade Brasileira de Diabetes 2019- 2020. Disponível em: https://www.saude.ba.gov.br/wp-content/uploads/2020/02/Diretrizes-Sociedade-Brasileira-de-Diabetes-2019-2020.pdf. Acessado em: 17 de abril de 2023
TAN E, et al. Effect of multidisciplinary intensive targeted care in improving diabetes mellitus outcomes: a randomized controlled pilot study - the Integrated Diabetes Education, Awareness and Lifestyle modification in Singapore (IDEALS) Program. Trials. 2019;20(1):549.
WEXLER DJ. Initial management of hyperglycemia in adults with type 2 diabetes mellitus. UpToDate. Waltham, MA: UpToDate 2022.
WEXLER DJ. Overview of general medical care in nonpregnant adults with diabetes mellitus. UpToDate. Waltham, MA: UpToDate 2023.
WEXLER L, et al. Management of persistent hyperglycemia in type 2 diabetes mellitus. UpToDate. Waltham, MA: UpToDate, 2023.
